2024-05-01 2025-04-30 false No description of principal activity Capium Accounts Production 1.1 10740299 2024-05-01 2025-04-30 10740299 bus:FullAccounts 2024-05-01 2025-04-30 10740299 bus:FRS102 2024-05-01 2025-04-30 10740299 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 10740299 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 10740299 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 10740299 2024-05-01 2025-04-30 10740299 2025-04-30 10740299 bus:RegisteredOffice 2024-05-01 2025-04-30 10740299 core:WithinOneYear 2025-04-30 10740299 core:AfterOneYear 2025-04-30 10740299 1 2024-05-01 2025-04-30 10740299 bus:Director1 2024-05-01 2025-04-30 10740299 bus:Director1 2025-04-30 10740299 bus:Director1 2023-05-01 2024-04-30 10740299 2023-05-01 10740299 bus:LeadAgentIfApplicable 2024-05-01 2025-04-30 10740299 2023-05-01 2024-04-30 10740299 2024-04-30 10740299 core:WithinOneYear 2024-04-30 10740299 core:AfterOneYear 2024-04-30 10740299 bus:EntityAccountantsOrAuditors 2023-05-01 2024-04-30 10740299 bus:OrdinaryShareClass1 2024-05-01 2025-04-30 10740299 bus:OrdinaryShareClass1 2025-04-30 10740299 bus:OrdinaryShareClass1 2023-05-01 2024-04-30 10740299 bus:OrdinaryShareClass1 2024-04-30 10740299 core:CostValuation core:Non-currentFinancialInstruments 2025-04-30 10740299 core:CostValuation core:Non-currentFinancialInstruments 2024-04-30 10740299 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-04-30 10740299 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-04-30 10740299 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-04-30 10740299 core:Non-currentFinancialInstruments 2025-04-30 10740299 core:Non-currentFinancialInstruments 2024-04-30 10740299 core:ShareCapital 2025-04-30 10740299 core:ShareCapital 2024-04-30 10740299 core:RetainedEarningsAccumulatedLosses 2025-04-30 10740299 core:RetainedEarningsAccumulatedLosses 2024-04-30 10740299 dpl:Item1 2024-05-01 10740299 dpl:Item1 2025-04-30 10740299 dpl:Item1 2023-05-01 10740299 dpl:Item1 2024-04-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 10740299
England and Wales

 

 

 

AMREEN SHOKAT MEDICAL LIMITED



Unaudited Financial Statements
 


Period of accounts

Start date: 01 May 2024

End date: 30 April 2025
 
 
Notes
 
2025
£
  2024
£
Current assets      
Cash at bank and in hand 484    1,615 
Creditors: amount falling due within one year 3 (1,406)   (1,405)
Net current assets (922)   210 
 
Total assets less current liabilities (922)   210 
Creditors: amount falling due after more than one year 4 (896)  
Net assets (1,818)   210 
 

Capital and reserves
     
Called up share capital 5 100    100 
Profit and loss account (1,918)   110 
Shareholders' funds (1,818)   210 
 


For the year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 11 June 2025 and were signed by:


-------------------------------
Amreen Shokat
Director
1
General Information
AMREEN SHOKAT MEDICAL LIMITED is a private company, limited by shares, registered in England and Wales, registration number 10740299, registration address 143 WESTBURY ROAD, WESTBURY ROAD ILFORD, IG1 3BW.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.

Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
2.

Average number of employees

Average number of employees during the year was 1 (2024 : 1).
3.

Creditors: amount falling due within one year

2025
£
  2024
£
Other Creditors 1   
Directors' Current Accounts 1,405    1,405 
1,406    1,405 

4.

Creditors: amount falling due after more than one year

2025
£
  2024
£
Directors' Loan Accounts 896   
896   

5.

Share Capital

Allotted, called up and fully paid
2025
£
  2024
£
100 Class A shares of £1.00 each 100    100 
100    100 

2